{"title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","markdown":{"yaml":{"title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","authors":[{"name":"dr. Kadek Adit Wiryadana","affiliation":"Universitas Udayana","roles":"writing","corresponding":true},{"name":"dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD","affiliation":"Universitas Udayana","roles":"writing","corresponding":false},{"name":"dr. Pande Ketut Kurniari, SpPD, K-R","affiliation":"Universitas Udayana","roles":"writing","corresponding":false}],"bibliography":"references.bib","csl":"wiryadana.csl"},"headingText":"Abstract","containsRefs":false,"markdown":"\n\n```{r, echo=F}\nlibrary(\"tidyverse\")\nlibrary(\"googlesheets4\")\n```\n\n\n**keywords**:\n\n## Pendahuluan\n\nKoinsidensi penyakit graves dan sistemik lupus eritematosus (SLE) belakangan ini mendapat perhatian lebih karena ditemukan memiliki hubungan yang tidak sekedar sesuatu yang terjadi secara acak. Hubungan kausal antara kedua entitas penyakit automimun tersebut masih belum banyak diketahui dan saat ini masih terdapat berbagai penelitian yang mendalami hal tersebut.[@xian2024] Penyakit graves merupakan salah satu penyakit autoimun pada organ endokrin thyroid dan merupakan penyebab utama hipertiroidisme.[@smith2016] Insiden enyakit Graves sebagai penyakit autoimun termasuk cukup tinggi dengan rentang 20 - 50 kasus per 100.000 individual serta tingkat prevalensi diperkirakan 1 - 1.5%.[@davies2020] Penyakit graves memilki target organ khusus, namun koinsidensi dengan penyakit autoimun lain seperti SLE, Rheumatoid arthritis, multiple sclerosis, diabetes tipe 1 dan lainnya diperkirakan sekitar 16.7% dari total pasien dengan penyakit graves. Data lebih lanjut dari laporan serial kasus terbaru. juga menunjukan bahwa persentase pasien dengan penyakit Graves juga ditemukan memiliki 3 penyakit autoimun lain sebesar 1.5%.[@ferrari2019]\n\nSLE merupakan penyakit yang memiliki variasi spektrum klinis yang luas akibat terget organ multipel dan heterogen. Penelitian kohort multisenter di China menemukan bahwa individu dengan penyakit graves lebih rentan mengalami SLE dibanding individu kontrol yang sehat.[@lee2020] Penelitian terbaru dari Xian et al dengan analisis randomisasi mendelian menemukan bahwa terdapat korelasi antara penyakit graves dan SLE, dan masing-masing entitas autoimun tersebut saling mendukung untuk koinsidensi autoimun lainnya. Temuan-temuan ini memberikan gambaran bahwa pada praktik klinis diharapkan klinisi dapat meningkatkan skrining penyakit autoimun khususnya penyakit graves atau SLE saat menegakan diagnosis salah satu penyakit autoimun tersebut.[@xian2024] Laporan kasus ini memaparkan seorang pasien perempuan dengan krisis tiroid akibat penyakit graves yang sebelumnya diketahui memiliki penyakit SLE.\n\n## Laporan Kasus\n\nSeorang perempuan (23066258) usia 23 tahun dirujuk dengan keluhan mual, pusing dan dada berdebar sejak 1 hari SMRS. Pasien sebelumnya dirawat selama 4 hari di RS perujuk namun tidak ada perbaikan. Keluhan lain yakni rambut rontok, ruam kemerahan pada pipi serta nyeri pada persendian kedua kaki yang muncul sejak 1 minggu sebelumnya. Riwayat penurunan berat badan 10 kg dalam kurun waktu 6 bulan terakhir. Saat di IGD pasien dalam kondisi compos mentis, tekanan darah 130/90 mmHg, denyut nadi 128 kali/menit, laju respirasi 24 kali/menit, saturasi oksigen 99% dengan udara ruangan dan suhu aksila 36.6 C. Pada pemeriksaan fisik, temuan signifikan meliputi sklera ikterus, ruam malar, bilateral pedal edema. Pemeriksaan elektrokardiografi menunjukan atrial fibrilasi dengan laju nadi 148 kali per menit. Pemeriksaan penunjang ditemukan anemia sedang normokromik normositer, trombositopenia, peningkatan Serum Glutamic Oxaloacetic Transaminase (SGOT), hipoalbuminemia, hipokalemia, alkalosis metabolik. Pada pemeriksaan foto thorax anteroposterior tak tampak kelainan pada pulmonum. Pada jantung terukur *Cardiothoracic Ratio* (CTR) 66 %, dengan *splaying carina*, apex mendatar, pinggang jantung melurus, conus pulmonum menonjol. Foto thorax tampak kesan kardiomegali dengan konfigurasi *left ventricular hipertrophy* dan *left atrial enlargement*.\n\n![Foto Polos Thorax Anteroposterior (6/11/2023) menunjukan kardiomegali dengan konfugurasi LVH dan LAE serta tak tampak kelainan pada pulmo.](image/thorax_ap.jpg){#fig-thorax}\n\n| Parameter           | Nilai Referensi         | 6/11/2023 | 7/11/2023 | 10/11/2023 |\n|-----------------|--------------|--------------|--------------|--------------|\n| WBC                 | 4.1 - 11.0 x 10^3^/µL   | 3.96      | 11.17     | 4.42       |\n| Neutrofil (absolut) | 2.50 - 7.50 x 10^3^/µL  | 2.77      | 9.29      | 3.41       |\n| Limfosit (absolut)  | 1.00 - 4.00 x 10^3^/µL  | 1.06      | 1.11      | 0.76       |\n| Monosit (absolut)   | 1.00 - 4.00 x 10^3^/µL  | 0.13      | 0.77      | 0.25       |\n| Eosinofil (absolut) | 0.00 - 0.50 x 10^3^/µL  | 0.00      | 0.00      | 0.00       |\n| Basofil (absolut)   | 0.0 - 0.1 x 10^3^/µL    | 0.00      | 0.00      | 0.00       |\n| Hemoglobin          | 12.0 - 16.0 g/dL        | 7.30      | 6.90      | 11.20      |\n| Hematokrit          | 36.0 - 46.0             | 23.10     | 21.50     | 33.10      |\n| MCV                 | 80.0 - 100.0 fL         | 85.90     | 85.30     | 82.80      |\n| MCH                 | 26.0 - 34.0 pg          | 27.10     | 27.40     | 28         |\n| MCHC                | 31 - 36 g/dL            | 31.60     | 32.10     | 33.80      |\n| Platetet            | 140 - 440 x 10^3^/µL    | 67.00     | 78.00     | 57         |\n\n: Data pemeriksaan darah lengkap selama perawatan pasien.\n\n| Pemeriksaan        | Parameter              | Referensi     | 6/11/2023 | 7/11                         | 12/11 | 14/11     | 16/11 |\n|---------|---------|---------|---------|---------|---------|---------|---------|\n| Marker Inflamasi   | LED                    | \\< 20         | 69        |                              |       |           |       |\n| Faal Hemostasis    | PPT                    | 10 - 12.7     | 15.9      |                              |       |           |       |\n|                    | INR                    | 0.9 - 1.1     | 1.45      |                              |       |           |       |\n|                    | APTT                   | 23-34.7       | 28.9      |                              |       |           |       |\n| Fungsi Ginjal      | BUN                    | 7.0 - 18.7    | 7.0       |                              |       |           |       |\n|                    | Kreatinin              | 0.57 - 1.11   | 0.51      |                              |       |           |       |\n|                    | e-LFG                  | \\>= 90        | 135.53    |                              |       |           |       |\n| Elektrolit         | Natrium                | 136 - 145     | 142       |                              |       |           |       |\n|                    | Kalium                 | 3.5 - 5.1     | 2.88      |                              |       |           |       |\n|                    | Kalsium                | 8.8 - 10.2    |           |                              |       | 7.7 (9.1) |       |\n| Fungsi Liver       | AST/SGOT               | 71            | \\<34      |                              |       | 123       |       |\n|                    | ALT/SGPT               | 44            | \\<55      |                              |       | 118       |       |\n|                    | Albumin                | 3.4 - 4.8     | 2.3       |                              |       |           |       |\n|                    | Globulin               | 2.2 - 3.7     | 4.10      |                              |       |           |       |\n|                    | Total Protein          | 6.4 - 8.3     | 6.4       |                              |       |           |       |\n|                    | Bilirubin Total        | 0.2 - 1.2     | 0.2 - 1.2 | 4.9                          | 5.60  | 4.20      |       |\n|                    | Bilirubin Direk        | 0.0 - 0.5     | 0.0 - 0.5 | 3.2                          | 3.37  | 2.13      |       |\n|                    | Bilirubin Indirek      | 0.2 - 0.7     | 0.2 - 0.7 | 1.70                         | 2.23  | 2.07      |       |\n|                    | Fosfatase Alkali (ALP) | 40 - 150      |           | 125                          |       |           |       |\n|                    | Gamma GT               | \\< 33         |           | 232                          |       |           |       |\n| Hepatitis Marker   | HBsAg                  | Non reaktif   |           | Non reaktif                  |       |           |       |\n|                    | Anti HCV               | Non reaktif   |           | Non reaktif                  |       |           |       |\n| Analisis Gas Darah | pH                     | 7.35 - 7.45   | 7.47      |                              |       |           |       |\n|                    | pCO2                   | 35 - 45       | 44        |                              |       |           |       |\n|                    | HCO3-                  | 22 - 26       | 32        |                              |       |           |       |\n|                    | BEecf                  | -2 s.d 2      | 83        |                              |       |           |       |\n|                    | pO2                    | 80 - 100%     | 75        |                              |       |           |       |\n|                    | SO2c                   | 95 - 100%     | 96        |                              |       |           |       |\n|                    | TCO2                   | 24 - 30       | 33.40     |                              |       |           |       |\n| Imunologi          | ANA-IF                 | \\< 1:100      |           | 1:10.00 (Pola fine Speckled) |       |           |       |\n|                    | TrAB (PRODIA)          | \\<= 1.75 IU/L |           |                              |       |           | 36.3  |\n| Fungsi Tiroid      | Free T4                | 0.7 - 1.48    |           | 28                           |       |           |       |\n|                    | TSHs                   | 0.27 - 4.20   |           | \\< 0.01                      |       |           |       |\n\nPemeriksaan apusan darah tepi menungjukan anemia normokromik, normositer dengan leukositosis dan thrombositopenia. Sebagian besar populasi sel normokromik normositer, anisopoikilositosis (ovalosit, sel tear drop, stomatosit, sel target, sel polikromasia, normoblast. Pada leukosit differential count ditemukan neutrofilia dan tidak ada sel muda. Pada thrombosit tidak ditemukan giant trombosit atau clumping.\n\n| Pemeriksaan Urin             | Parameter                | Referensi       | 7/11/2023 |\n|-------------------|-------------------|------------------|------------------|\n| Urine Lengkap                | Berat Jenis              | 1.003 - 1.035   | 1.009     |\n|                              | Warna                    | Kuning          | Kuning    |\n|                              | Kekeruhan                |                 | Jernih    |\n|                              | pH                       | 4.5 - 8         | 7.5       |\n|                              | Leukosit                 | Negatif         | Negatif   |\n|                              | Nitrit                   | Negatif         | Negatif   |\n|                              | Protein                  | Negatif         | Negatif   |\n|                              | Glukosa                  | Negatif         | Negatif   |\n|                              | Keton                    | Negatif         | Negatif   |\n|                              | Darah                    | Negatif         | Negatif   |\n|                              | Urobilinogen             | Normal          | Normal    |\n|                              | Bilirubin                | Negatif         | Negatif   |\n|                              | Leukosit Sedimen         | 7 /LPB          | 5         |\n|                              | Eritrosit Sedimen        | 5 /LPB          | 4         |\n|                              | Sel Epitel Sedimen       | 8 /LPB          | 1         |\n|                              | Silinder                 | 2.4 /mikroliter | 0.14      |\n|                              | Bakteri                  | 130.7           | 1993.8    |\n| Rasio Protein kreatinin urin | Mikro Total protein urin | 1 - 14 mg/dl    | 24.10     |\n|                              | Kreatinin urin           | 63 - 166        | 2.41      |\n|                              | Rasio protein kreatinin  | 2.41            | \\< 0.2    |\n\n| Tangal pemeriksaan | Kalium |\n|--------------------|--------|\n| 6/11/24            | 2.88   |\n| 8/11/24            | 2.95   |\n| 8/11/24            | 2.45   |\n| 9/11/24            | 3.91   |\n| 15/11/24           | 2.25   |\n| 16/11/24           | 3.18   |\n\nPada pemeriksaan ultrasonografi Tiroid ditemukan peningkatan vaskularisasi pada parenkim tiroid kanan, kiri dan istmus. Pada pemeriksaan tidak ditemukan massa/nodul/kista pada kelenjar tiroid, namun tampak pembesaran kelenjar getah bening pada regio colli kiri, submandibula kanan-kiri, preaurikula kanan dan parotid kiri. Kelenjar parotis kanan tak tampak kelainan. Pemeriksaan USG ini mendukung *Graves Disease* dengan multipel *non suspicious* limfadenopati pada regio colli kiri, submandibula kanan-kiri, preauricula kanan, dan parotid kiri.\n\n::: {layout-nrow=3}\n![USG Tiroid Lobus Kanan](/image/usg_tiroid/tiroid_RLobe.png)\n\n![USG Tiroid Istmus](/image/usg_tiroid/tiroid_istmus.png)\n\n![USG Tiroid Lobus Kiri](/image/usg_tiroid/tiroid_LLobe.png)\n:::\n\nPada pemeriksaan ultrasonografi abdomen ditemukan nodul tunggal hipoechoic dengan hiperechoic di tepinya dan internal echo didalamnya, berbatas tegas tepi regular pada segmen VIII hepar, terukur +/- 1.8 x 1.7 cm yang pada CDUS tampak vaskularisasi pada tepinya. Pada pencitraan cavum pelvis, ditemukan cairan bebas minimal.\n\n![USG abdomen (9/11/2023) ditemukan liver tidak membesar, permukaan licin, sudut tajam, tepi rata, sistem vasculer dan bilier tampak normal, echoparenchym normal, tampak single nodul hipoechoic dengan hiperechoic di tepinya dan internal echo didalamnya, berbatas tegas tepi regular pada segmen VIII hepar, terukur +/- 1.8 x 1.7 cm yang pada CDUS tampak vaskularisasi pada tepinya](image/usg_abd/abd_nodul.png){fig-align=\"left\"}\n\n## Diskusi\n\nPenelitian terbaru oleh Xian et al menemukan bahwa SLE meningkatkan risiko penyaki graves (OR=1.13, 95% CI 1.05-1.22, p =0.003), dan berlaku juga sebaliknya penyakit graves meningkatkan risiko SLE (OR=1.27, 95% CI 1.09-1.48, p =0.018).[@xian2024] Hubungan sebab akibat antara penyakit graves dan SLE yang ditemukan dalam penelitian tersebut semakin menegaskan temuan epidemiologi sebelumnya. Patogenesis SLE dan penyakit graves mungkin dipengaruhi oleh mutasi pada gen HLA. Sebuah meta-analisis yang dilakukan sebelumnya menemukan bahwa mutasi pada HLA-DR3 dan HLA-DR15 secara signifikan meningkatkan kemungkinan SLE.[@xue_2018] Kehadiran gen HLA yang bermutasi dapat mengakibatkan perubahan kompleks HLA pada sel penyaji antigen, sehingga mempengaruhi interaksi antara sel B dan T. Situasi ini dapat menyebabkan disregulasi sel B yang reaktif terhadap diri sendiri dan produksi autoantibodi, yang dapat berfungsi sebagai mediator efek kausal SLE pada penyakit graves.[@xian2024]\n\nSelain gen terkait HLA, gen non-HLA juga diduga memainkan peran penting dalam interaksi antara SLE dan penyakit graves. Protein terkait limfosit T sitotoksik 4 (CTLA-4) adalah reseptor protein yang berfungsi sebagai cek poin pemeriksaan imun untuk menurunkan regulasi respons imun dengan mengikat ligan CD80 dan CD86 pada permukaan sel penyaji antigen, sehingga mengatur aktivasi sel T dan proliferasinya.[@syn2017] Mutasi pada gen CTLA-4 telah dikaitkan dengan SLE dan penyakit graves. Sebuah meta-analisis menunjukkan bahwa polimorfisme gen CTLA-4 pada populasi Asia dikaitkan dengan risiko SLE.[@zhai2013] Sebuah studi oleh Lee dkk. menemukan bahwa beberapa polimorfisme nukleotida tunggal CTLA-4 dikaitkan dengan penyakit graves dan penyakit tiroid autoimun seperti tiroiditis Hashimoto.[@lee2015] Mutasi pada gen CTLA-4 dapat menyebabkan defisiensi regulasi penurunan regulasi respon imun sel T, yang mengakibatkan hiperaktivasi sel T dan dengan demikian memicu penyakit autoimun. Faktor ini mungkin juga memainkan peran mediasi dalam hubungan antara penyakit graves dan SLE.[@xian2024]\n\nSLE dan penyakit graves ditandai oleh kelainan regulasi imun yang mungkin berhubungan erat dengan interferon tipe I (IFN-I).[@pan2019] Interferon tipe I, termasuk IFN-a, IFN-b, IFN-ϵ, IFN-k, dll., adalah sitokin yang memainkan peran penting dalam peradangan, regulasi kekebalan, pengenalan sel tumor, dan respons sel T. Dalam konteks penyakit autoimun, IFN-I dapat berkontribusi pada perkembangan SLE dengan meningkatkan presentasi antigen dan respon limfosit serta menginduksi ekspresi kemokin. IFN-I meningkatkan aktivasi sel B, diferensiasi, proliferasi dan produksi antibodi, dan dapat menginduksi ekspresi reseptor *Thyroid-timulating hormone*.[@ivashkiv2013] Dengan demikian, hal ini mungkin berdampak pada menignkatnya risiko penyakit graves.\n\nSelain regulasi imun yang menyimpang, SLE dan penyakit graves mungkin memiliki patogenesis yang sama terkait autoantibodi yang menyebabkan kerusakan jaringan. Sebuah meta-analisis yang dilakukan oleh Pan et al. menunjukkan bahwa kadar antibodi tiroid peroksidase (TPOAb) dan antibodi tiroglobulin (TgAb) jauh lebih tinggi pada pasien SLE dibandingkan dengan populasi sehat, yang menunjukkan adanya korelasi antara SLE dan penyakit tiroid autoimun.[@pan2015] Penelitian yang dilakukan oleh Lanzolla dkk. menunjukkan bahwa keberadaan antibodi antinuklear diamati pada sekitar 80% pasien yang didiagnosis dengan penyakit graves. Temuan ini menunjukkan bahwa penyakit graves berpotensi mempengaruhi perkembangan SLE melalui jalur autoantibodi.[@lanzolla2022]\n\nJalur imunologi yang sama dalam perkembangan SLE dan penyakit graves ditunjukkan oleh adanya tumpang tindih kemokin dan sitokin spesifik. Penelitian terbaru berfokus pada interaksi antara CXCL10 dan CXCR3 dalam respon imun T helper 1 sangat penting dalam etiologi penyakit graves dan SLE.[@antonelli2014; @antonelli2020] Selain itu, dilaporkan bahwa peningkatan kadar IL-37 berkorelasi positif dengan konsentrasi TRAb dan derajat aktivitas SLE, sehingga ini menunjukkan bahwa IL-37 memainkan peran penting dalam terjadinya penyakit graves dan SLE.[@xu2015]\n\n## Ringkasan\n\nPenyakit Graves secara genetik diprediksi meningkatkan risiko SLE, dan berlaku juga sebaliknya. Laporan kasus ini diharapkan dapat memberikan dasar baru untuk skrining dan tatalaksana pasien dengan penyakit graves yang memiliki gejala baru yang tidak spesifik harus diskrining untuk SLE sehingga memfasilitasi diagnosis dan pengobatan tepat waktu dan menghindari penundaan atau eksaserbasi penyakit. Pada saat yang sama, fungsi tiroid juga perlu dipantau selama penatalaksanaan pasien SLE, sehingga dapat menyesuaikan rencana pengobatan dan menjamin kualitas hidup pasien.\n\n## Daftar Pustaka\n","srcMarkdownNoYaml":"\n\n```{r, echo=F}\nlibrary(\"tidyverse\")\nlibrary(\"googlesheets4\")\n```\n\n## Abstract\n\n**keywords**:\n\n## Pendahuluan\n\nKoinsidensi penyakit graves dan sistemik lupus eritematosus (SLE) belakangan ini mendapat perhatian lebih karena ditemukan memiliki hubungan yang tidak sekedar sesuatu yang terjadi secara acak. Hubungan kausal antara kedua entitas penyakit automimun tersebut masih belum banyak diketahui dan saat ini masih terdapat berbagai penelitian yang mendalami hal tersebut.[@xian2024] Penyakit graves merupakan salah satu penyakit autoimun pada organ endokrin thyroid dan merupakan penyebab utama hipertiroidisme.[@smith2016] Insiden enyakit Graves sebagai penyakit autoimun termasuk cukup tinggi dengan rentang 20 - 50 kasus per 100.000 individual serta tingkat prevalensi diperkirakan 1 - 1.5%.[@davies2020] Penyakit graves memilki target organ khusus, namun koinsidensi dengan penyakit autoimun lain seperti SLE, Rheumatoid arthritis, multiple sclerosis, diabetes tipe 1 dan lainnya diperkirakan sekitar 16.7% dari total pasien dengan penyakit graves. Data lebih lanjut dari laporan serial kasus terbaru. juga menunjukan bahwa persentase pasien dengan penyakit Graves juga ditemukan memiliki 3 penyakit autoimun lain sebesar 1.5%.[@ferrari2019]\n\nSLE merupakan penyakit yang memiliki variasi spektrum klinis yang luas akibat terget organ multipel dan heterogen. Penelitian kohort multisenter di China menemukan bahwa individu dengan penyakit graves lebih rentan mengalami SLE dibanding individu kontrol yang sehat.[@lee2020] Penelitian terbaru dari Xian et al dengan analisis randomisasi mendelian menemukan bahwa terdapat korelasi antara penyakit graves dan SLE, dan masing-masing entitas autoimun tersebut saling mendukung untuk koinsidensi autoimun lainnya. Temuan-temuan ini memberikan gambaran bahwa pada praktik klinis diharapkan klinisi dapat meningkatkan skrining penyakit autoimun khususnya penyakit graves atau SLE saat menegakan diagnosis salah satu penyakit autoimun tersebut.[@xian2024] Laporan kasus ini memaparkan seorang pasien perempuan dengan krisis tiroid akibat penyakit graves yang sebelumnya diketahui memiliki penyakit SLE.\n\n## Laporan Kasus\n\nSeorang perempuan (23066258) usia 23 tahun dirujuk dengan keluhan mual, pusing dan dada berdebar sejak 1 hari SMRS. Pasien sebelumnya dirawat selama 4 hari di RS perujuk namun tidak ada perbaikan. Keluhan lain yakni rambut rontok, ruam kemerahan pada pipi serta nyeri pada persendian kedua kaki yang muncul sejak 1 minggu sebelumnya. Riwayat penurunan berat badan 10 kg dalam kurun waktu 6 bulan terakhir. Saat di IGD pasien dalam kondisi compos mentis, tekanan darah 130/90 mmHg, denyut nadi 128 kali/menit, laju respirasi 24 kali/menit, saturasi oksigen 99% dengan udara ruangan dan suhu aksila 36.6 C. Pada pemeriksaan fisik, temuan signifikan meliputi sklera ikterus, ruam malar, bilateral pedal edema. Pemeriksaan elektrokardiografi menunjukan atrial fibrilasi dengan laju nadi 148 kali per menit. Pemeriksaan penunjang ditemukan anemia sedang normokromik normositer, trombositopenia, peningkatan Serum Glutamic Oxaloacetic Transaminase (SGOT), hipoalbuminemia, hipokalemia, alkalosis metabolik. Pada pemeriksaan foto thorax anteroposterior tak tampak kelainan pada pulmonum. Pada jantung terukur *Cardiothoracic Ratio* (CTR) 66 %, dengan *splaying carina*, apex mendatar, pinggang jantung melurus, conus pulmonum menonjol. Foto thorax tampak kesan kardiomegali dengan konfigurasi *left ventricular hipertrophy* dan *left atrial enlargement*.\n\n![Foto Polos Thorax Anteroposterior (6/11/2023) menunjukan kardiomegali dengan konfugurasi LVH dan LAE serta tak tampak kelainan pada pulmo.](image/thorax_ap.jpg){#fig-thorax}\n\n| Parameter           | Nilai Referensi         | 6/11/2023 | 7/11/2023 | 10/11/2023 |\n|-----------------|--------------|--------------|--------------|--------------|\n| WBC                 | 4.1 - 11.0 x 10^3^/µL   | 3.96      | 11.17     | 4.42       |\n| Neutrofil (absolut) | 2.50 - 7.50 x 10^3^/µL  | 2.77      | 9.29      | 3.41       |\n| Limfosit (absolut)  | 1.00 - 4.00 x 10^3^/µL  | 1.06      | 1.11      | 0.76       |\n| Monosit (absolut)   | 1.00 - 4.00 x 10^3^/µL  | 0.13      | 0.77      | 0.25       |\n| Eosinofil (absolut) | 0.00 - 0.50 x 10^3^/µL  | 0.00      | 0.00      | 0.00       |\n| Basofil (absolut)   | 0.0 - 0.1 x 10^3^/µL    | 0.00      | 0.00      | 0.00       |\n| Hemoglobin          | 12.0 - 16.0 g/dL        | 7.30      | 6.90      | 11.20      |\n| Hematokrit          | 36.0 - 46.0             | 23.10     | 21.50     | 33.10      |\n| MCV                 | 80.0 - 100.0 fL         | 85.90     | 85.30     | 82.80      |\n| MCH                 | 26.0 - 34.0 pg          | 27.10     | 27.40     | 28         |\n| MCHC                | 31 - 36 g/dL            | 31.60     | 32.10     | 33.80      |\n| Platetet            | 140 - 440 x 10^3^/µL    | 67.00     | 78.00     | 57         |\n\n: Data pemeriksaan darah lengkap selama perawatan pasien.\n\n| Pemeriksaan        | Parameter              | Referensi     | 6/11/2023 | 7/11                         | 12/11 | 14/11     | 16/11 |\n|---------|---------|---------|---------|---------|---------|---------|---------|\n| Marker Inflamasi   | LED                    | \\< 20         | 69        |                              |       |           |       |\n| Faal Hemostasis    | PPT                    | 10 - 12.7     | 15.9      |                              |       |           |       |\n|                    | INR                    | 0.9 - 1.1     | 1.45      |                              |       |           |       |\n|                    | APTT                   | 23-34.7       | 28.9      |                              |       |           |       |\n| Fungsi Ginjal      | BUN                    | 7.0 - 18.7    | 7.0       |                              |       |           |       |\n|                    | Kreatinin              | 0.57 - 1.11   | 0.51      |                              |       |           |       |\n|                    | e-LFG                  | \\>= 90        | 135.53    |                              |       |           |       |\n| Elektrolit         | Natrium                | 136 - 145     | 142       |                              |       |           |       |\n|                    | Kalium                 | 3.5 - 5.1     | 2.88      |                              |       |           |       |\n|                    | Kalsium                | 8.8 - 10.2    |           |                              |       | 7.7 (9.1) |       |\n| Fungsi Liver       | AST/SGOT               | 71            | \\<34      |                              |       | 123       |       |\n|                    | ALT/SGPT               | 44            | \\<55      |                              |       | 118       |       |\n|                    | Albumin                | 3.4 - 4.8     | 2.3       |                              |       |           |       |\n|                    | Globulin               | 2.2 - 3.7     | 4.10      |                              |       |           |       |\n|                    | Total Protein          | 6.4 - 8.3     | 6.4       |                              |       |           |       |\n|                    | Bilirubin Total        | 0.2 - 1.2     | 0.2 - 1.2 | 4.9                          | 5.60  | 4.20      |       |\n|                    | Bilirubin Direk        | 0.0 - 0.5     | 0.0 - 0.5 | 3.2                          | 3.37  | 2.13      |       |\n|                    | Bilirubin Indirek      | 0.2 - 0.7     | 0.2 - 0.7 | 1.70                         | 2.23  | 2.07      |       |\n|                    | Fosfatase Alkali (ALP) | 40 - 150      |           | 125                          |       |           |       |\n|                    | Gamma GT               | \\< 33         |           | 232                          |       |           |       |\n| Hepatitis Marker   | HBsAg                  | Non reaktif   |           | Non reaktif                  |       |           |       |\n|                    | Anti HCV               | Non reaktif   |           | Non reaktif                  |       |           |       |\n| Analisis Gas Darah | pH                     | 7.35 - 7.45   | 7.47      |                              |       |           |       |\n|                    | pCO2                   | 35 - 45       | 44        |                              |       |           |       |\n|                    | HCO3-                  | 22 - 26       | 32        |                              |       |           |       |\n|                    | BEecf                  | -2 s.d 2      | 83        |                              |       |           |       |\n|                    | pO2                    | 80 - 100%     | 75        |                              |       |           |       |\n|                    | SO2c                   | 95 - 100%     | 96        |                              |       |           |       |\n|                    | TCO2                   | 24 - 30       | 33.40     |                              |       |           |       |\n| Imunologi          | ANA-IF                 | \\< 1:100      |           | 1:10.00 (Pola fine Speckled) |       |           |       |\n|                    | TrAB (PRODIA)          | \\<= 1.75 IU/L |           |                              |       |           | 36.3  |\n| Fungsi Tiroid      | Free T4                | 0.7 - 1.48    |           | 28                           |       |           |       |\n|                    | TSHs                   | 0.27 - 4.20   |           | \\< 0.01                      |       |           |       |\n\nPemeriksaan apusan darah tepi menungjukan anemia normokromik, normositer dengan leukositosis dan thrombositopenia. Sebagian besar populasi sel normokromik normositer, anisopoikilositosis (ovalosit, sel tear drop, stomatosit, sel target, sel polikromasia, normoblast. Pada leukosit differential count ditemukan neutrofilia dan tidak ada sel muda. Pada thrombosit tidak ditemukan giant trombosit atau clumping.\n\n| Pemeriksaan Urin             | Parameter                | Referensi       | 7/11/2023 |\n|-------------------|-------------------|------------------|------------------|\n| Urine Lengkap                | Berat Jenis              | 1.003 - 1.035   | 1.009     |\n|                              | Warna                    | Kuning          | Kuning    |\n|                              | Kekeruhan                |                 | Jernih    |\n|                              | pH                       | 4.5 - 8         | 7.5       |\n|                              | Leukosit                 | Negatif         | Negatif   |\n|                              | Nitrit                   | Negatif         | Negatif   |\n|                              | Protein                  | Negatif         | Negatif   |\n|                              | Glukosa                  | Negatif         | Negatif   |\n|                              | Keton                    | Negatif         | Negatif   |\n|                              | Darah                    | Negatif         | Negatif   |\n|                              | Urobilinogen             | Normal          | Normal    |\n|                              | Bilirubin                | Negatif         | Negatif   |\n|                              | Leukosit Sedimen         | 7 /LPB          | 5         |\n|                              | Eritrosit Sedimen        | 5 /LPB          | 4         |\n|                              | Sel Epitel Sedimen       | 8 /LPB          | 1         |\n|                              | Silinder                 | 2.4 /mikroliter | 0.14      |\n|                              | Bakteri                  | 130.7           | 1993.8    |\n| Rasio Protein kreatinin urin | Mikro Total protein urin | 1 - 14 mg/dl    | 24.10     |\n|                              | Kreatinin urin           | 63 - 166        | 2.41      |\n|                              | Rasio protein kreatinin  | 2.41            | \\< 0.2    |\n\n| Tangal pemeriksaan | Kalium |\n|--------------------|--------|\n| 6/11/24            | 2.88   |\n| 8/11/24            | 2.95   |\n| 8/11/24            | 2.45   |\n| 9/11/24            | 3.91   |\n| 15/11/24           | 2.25   |\n| 16/11/24           | 3.18   |\n\nPada pemeriksaan ultrasonografi Tiroid ditemukan peningkatan vaskularisasi pada parenkim tiroid kanan, kiri dan istmus. Pada pemeriksaan tidak ditemukan massa/nodul/kista pada kelenjar tiroid, namun tampak pembesaran kelenjar getah bening pada regio colli kiri, submandibula kanan-kiri, preaurikula kanan dan parotid kiri. Kelenjar parotis kanan tak tampak kelainan. Pemeriksaan USG ini mendukung *Graves Disease* dengan multipel *non suspicious* limfadenopati pada regio colli kiri, submandibula kanan-kiri, preauricula kanan, dan parotid kiri.\n\n::: {layout-nrow=3}\n![USG Tiroid Lobus Kanan](/image/usg_tiroid/tiroid_RLobe.png)\n\n![USG Tiroid Istmus](/image/usg_tiroid/tiroid_istmus.png)\n\n![USG Tiroid Lobus Kiri](/image/usg_tiroid/tiroid_LLobe.png)\n:::\n\nPada pemeriksaan ultrasonografi abdomen ditemukan nodul tunggal hipoechoic dengan hiperechoic di tepinya dan internal echo didalamnya, berbatas tegas tepi regular pada segmen VIII hepar, terukur +/- 1.8 x 1.7 cm yang pada CDUS tampak vaskularisasi pada tepinya. Pada pencitraan cavum pelvis, ditemukan cairan bebas minimal.\n\n![USG abdomen (9/11/2023) ditemukan liver tidak membesar, permukaan licin, sudut tajam, tepi rata, sistem vasculer dan bilier tampak normal, echoparenchym normal, tampak single nodul hipoechoic dengan hiperechoic di tepinya dan internal echo didalamnya, berbatas tegas tepi regular pada segmen VIII hepar, terukur +/- 1.8 x 1.7 cm yang pada CDUS tampak vaskularisasi pada tepinya](image/usg_abd/abd_nodul.png){fig-align=\"left\"}\n\n## Diskusi\n\nPenelitian terbaru oleh Xian et al menemukan bahwa SLE meningkatkan risiko penyaki graves (OR=1.13, 95% CI 1.05-1.22, p =0.003), dan berlaku juga sebaliknya penyakit graves meningkatkan risiko SLE (OR=1.27, 95% CI 1.09-1.48, p =0.018).[@xian2024] Hubungan sebab akibat antara penyakit graves dan SLE yang ditemukan dalam penelitian tersebut semakin menegaskan temuan epidemiologi sebelumnya. Patogenesis SLE dan penyakit graves mungkin dipengaruhi oleh mutasi pada gen HLA. Sebuah meta-analisis yang dilakukan sebelumnya menemukan bahwa mutasi pada HLA-DR3 dan HLA-DR15 secara signifikan meningkatkan kemungkinan SLE.[@xue_2018] Kehadiran gen HLA yang bermutasi dapat mengakibatkan perubahan kompleks HLA pada sel penyaji antigen, sehingga mempengaruhi interaksi antara sel B dan T. Situasi ini dapat menyebabkan disregulasi sel B yang reaktif terhadap diri sendiri dan produksi autoantibodi, yang dapat berfungsi sebagai mediator efek kausal SLE pada penyakit graves.[@xian2024]\n\nSelain gen terkait HLA, gen non-HLA juga diduga memainkan peran penting dalam interaksi antara SLE dan penyakit graves. Protein terkait limfosit T sitotoksik 4 (CTLA-4) adalah reseptor protein yang berfungsi sebagai cek poin pemeriksaan imun untuk menurunkan regulasi respons imun dengan mengikat ligan CD80 dan CD86 pada permukaan sel penyaji antigen, sehingga mengatur aktivasi sel T dan proliferasinya.[@syn2017] Mutasi pada gen CTLA-4 telah dikaitkan dengan SLE dan penyakit graves. Sebuah meta-analisis menunjukkan bahwa polimorfisme gen CTLA-4 pada populasi Asia dikaitkan dengan risiko SLE.[@zhai2013] Sebuah studi oleh Lee dkk. menemukan bahwa beberapa polimorfisme nukleotida tunggal CTLA-4 dikaitkan dengan penyakit graves dan penyakit tiroid autoimun seperti tiroiditis Hashimoto.[@lee2015] Mutasi pada gen CTLA-4 dapat menyebabkan defisiensi regulasi penurunan regulasi respon imun sel T, yang mengakibatkan hiperaktivasi sel T dan dengan demikian memicu penyakit autoimun. Faktor ini mungkin juga memainkan peran mediasi dalam hubungan antara penyakit graves dan SLE.[@xian2024]\n\nSLE dan penyakit graves ditandai oleh kelainan regulasi imun yang mungkin berhubungan erat dengan interferon tipe I (IFN-I).[@pan2019] Interferon tipe I, termasuk IFN-a, IFN-b, IFN-ϵ, IFN-k, dll., adalah sitokin yang memainkan peran penting dalam peradangan, regulasi kekebalan, pengenalan sel tumor, dan respons sel T. Dalam konteks penyakit autoimun, IFN-I dapat berkontribusi pada perkembangan SLE dengan meningkatkan presentasi antigen dan respon limfosit serta menginduksi ekspresi kemokin. IFN-I meningkatkan aktivasi sel B, diferensiasi, proliferasi dan produksi antibodi, dan dapat menginduksi ekspresi reseptor *Thyroid-timulating hormone*.[@ivashkiv2013] Dengan demikian, hal ini mungkin berdampak pada menignkatnya risiko penyakit graves.\n\nSelain regulasi imun yang menyimpang, SLE dan penyakit graves mungkin memiliki patogenesis yang sama terkait autoantibodi yang menyebabkan kerusakan jaringan. Sebuah meta-analisis yang dilakukan oleh Pan et al. menunjukkan bahwa kadar antibodi tiroid peroksidase (TPOAb) dan antibodi tiroglobulin (TgAb) jauh lebih tinggi pada pasien SLE dibandingkan dengan populasi sehat, yang menunjukkan adanya korelasi antara SLE dan penyakit tiroid autoimun.[@pan2015] Penelitian yang dilakukan oleh Lanzolla dkk. menunjukkan bahwa keberadaan antibodi antinuklear diamati pada sekitar 80% pasien yang didiagnosis dengan penyakit graves. Temuan ini menunjukkan bahwa penyakit graves berpotensi mempengaruhi perkembangan SLE melalui jalur autoantibodi.[@lanzolla2022]\n\nJalur imunologi yang sama dalam perkembangan SLE dan penyakit graves ditunjukkan oleh adanya tumpang tindih kemokin dan sitokin spesifik. Penelitian terbaru berfokus pada interaksi antara CXCL10 dan CXCR3 dalam respon imun T helper 1 sangat penting dalam etiologi penyakit graves dan SLE.[@antonelli2014; @antonelli2020] Selain itu, dilaporkan bahwa peningkatan kadar IL-37 berkorelasi positif dengan konsentrasi TRAb dan derajat aktivitas SLE, sehingga ini menunjukkan bahwa IL-37 memainkan peran penting dalam terjadinya penyakit graves dan SLE.[@xu2015]\n\n## Ringkasan\n\nPenyakit Graves secara genetik diprediksi meningkatkan risiko SLE, dan berlaku juga sebaliknya. Laporan kasus ini diharapkan dapat memberikan dasar baru untuk skrining dan tatalaksana pasien dengan penyakit graves yang memiliki gejala baru yang tidak spesifik harus diskrining untuk SLE sehingga memfasilitasi diagnosis dan pengobatan tepat waktu dan menghindari penundaan atau eksaserbasi penyakit. Pada saat yang sama, fungsi tiroid juga perlu dipantau selama penatalaksanaan pasien SLE, sehingga dapat menyesuaikan rencana pengobatan dan menjamin kualitas hidup pasien.\n\n## Daftar Pustaka\n"},"formats":{"html":{"identifier":{"display-name":"HTML","target-format":"html","base-format":"html"},"execute":{"fig-width":7,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":false,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":true,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"notebook-links":true,"format-links":[{"text":"MECA Bundle","href":"index-meca.zip","icon":"archive","attr":{"data-meca-link":"true"},"order":1000}],"notebook-preserve-cells":true},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","to":"html","toc":true,"output-file":"index.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words"},"metadata":{"lang":"en","fig-responsive":true,"quarto-version":"1.4.551","manuscript":{"article":"index.qmd","notebooks":[{"notebook":"index.qmd","title":"Article Notebook"}],"mecaFile":"index-meca.zip"},"quarto-internal":{"subarticles":[{"input":"/home/adit/R.project/lapsus_sle_graves/index.qmd","token":"nb-article","render":true}]},"notebook-preview-options":{"back":true},"theme":"cosmo","title-block-style":"manuscript","lightbox":"auto","comments":{"hypothesis":true},"title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","authors":[{"name":"dr. Kadek Adit Wiryadana","affiliation":"Universitas Udayana","roles":"writing","corresponding":true},{"name":"dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD","affiliation":"Universitas Udayana","roles":"writing","corresponding":false},{"name":"dr. Pande Ketut Kurniari, SpPD, K-R","affiliation":"Universitas Udayana","roles":"writing","corresponding":false}],"bibliography":["references.bib"],"csl":"wiryadana.csl","google-scholar":true,"toc-location":"left","clear-hidden-classes":"none","remove-hidden":"all","unroll-markdown-cells":true},"extensions":{"book":{"multiFile":true}}},"docx":{"identifier":{"display-name":"MS Word","target-format":"docx","base-format":"docx"},"execute":{"fig-width":5,"fig-height":4,"fig-format":"png","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":false,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":true,"prefer-html":false,"output-divs":true,"output-ext":"docx","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":true,"merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"page-width":6.5,"format-links":[{"text":"MECA Bundle","href":"index-meca.zip","icon":"archive","attr":{"data-meca-link":"true"},"order":1000}],"notebook-preserve-cells":true},"pandoc":{"default-image-extension":"png","to":"docx","output-file":"index.docx"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words"},"metadata":{"manuscript":{"article":"index.qmd","notebooks":[{"notebook":"index.qmd","title":"Article Notebook"}],"mecaFile":"index-meca.zip"},"quarto-internal":{"subarticles":[{"input":"/home/adit/R.project/lapsus_sle_graves/index.qmd","token":"nb-article","render":true}]},"notebook-preview-options":{"back":true},"theme":"cosmo","title-block-style":"manuscript","lightbox":"auto","title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","authors":[{"name":"dr. Kadek Adit Wiryadana","affiliation":"Universitas Udayana","roles":"writing","corresponding":true},{"name":"dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD","affiliation":"Universitas Udayana","roles":"writing","corresponding":false},{"name":"dr. Pande Ketut Kurniari, SpPD, K-R","affiliation":"Universitas Udayana","roles":"writing","corresponding":false}],"bibliography":["references.bib"],"csl":"wiryadana.csl","google-scholar":true,"clear-hidden-classes":"none","remove-hidden":"all","unroll-markdown-cells":true},"extensions":{"book":{"selfContainedOutput":true}}},"jats":{"identifier":{"display-name":"JATS","target-format":"jats","base-format":"jats"},"execute":{"fig-width":7,"fig-height":5,"fig-format":"png","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":false,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":true,"prefer-html":false,"output-divs":true,"output-ext":"xml","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":true,"merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"variant":"+element_citations","format-links":[{"text":"MECA Bundle","href":"index-meca.zip","icon":"archive","attr":{"data-meca-link":"true"},"order":1000}],"notebook-preserve-cells":true},"pandoc":{"standalone":true,"default-image-extension":"png","to":"jats","output-file":"index.xml"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words"},"metadata":{"manuscript":{"article":"index.qmd","notebooks":[{"notebook":"index.qmd","title":"Article Notebook"}],"mecaFile":"index-meca.zip"},"quarto-internal":{"subarticles":[{"input":"/home/adit/R.project/lapsus_sle_graves/index.qmd","token":"nb-article","render":true}]},"notebook-preview-options":{"back":true},"theme":"cosmo","title-block-style":"manuscript","lightbox":"auto","title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","authors":[{"name":"dr. Kadek Adit Wiryadana","affiliation":"Universitas Udayana","roles":"writing","corresponding":true},{"name":"dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD","affiliation":"Universitas Udayana","roles":"writing","corresponding":false},{"name":"dr. Pande Ketut Kurniari, SpPD, K-R","affiliation":"Universitas Udayana","roles":"writing","corresponding":false}],"bibliography":["references.bib"],"csl":"wiryadana.csl","google-scholar":true,"clear-hidden-classes":"none","remove-hidden":"all","unroll-markdown-cells":true}},"plos-pdf":{"identifier":{"display-name":"PDF","target-format":"plos-pdf","base-format":"pdf","extension-name":"plos"},"execute":{"fig-width":5.5,"fig-height":3.5,"fig-format":"pdf","fig-dpi":300,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":false,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":true,"keep-typ":false,"keep-source":false,"keep-hidden":true,"prefer-html":false,"output-divs":true,"output-ext":"pdf","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":true,"merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":["_extensions/quarto-journals/plos/plos2015.bst"],"shortcodes":[],"format-links":[{"text":"MECA Bundle","href":"index-meca.zip","icon":"archive","attr":{"data-meca-link":"true"},"order":1000}],"notebook-preserve-cells":true},"pandoc":{"pdf-engine":"pdflatex","standalone":true,"variables":{"graphics":true,"tables":true},"default-image-extension":"pdf","to":"pdf","filters":["/home/adit/R.project/lapsus_sle_graves/_extensions/quarto-journals/plos/filter.lua"],"toc":false,"include-in-header":["_extensions/quarto-journals/plos/_preamble.tex"],"cite-method":"natbib","output-file":"index.pdf"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words"},"metadata":{"block-headings":false,"crossref":{"fig-prefix":"Fig","eq-prefix":"Eq"},"callout-appearance":"simple","callout-icon":false,"csl":"wiryadana.csl","documentclass":"article","papersize":"letter","fontsize":"10pt","has-frontmatter":false,"lof":false,"lot":false,"colorlinks":false,"geometry":["top=0.85in","left=2.75in","footskip=0.75in"],"biblio-style":"plos2015","template-partials":["_extensions/quarto-journals/plos/partials/doc-class.tex","_extensions/quarto-journals/plos/partials/before-body.tex","_extensions/quarto-journals/plos/partials/_authors.tex","_extensions/quarto-journals/plos/partials/_affiliations.tex","_extensions/quarto-journals/plos/partials/title.tex","_extensions/quarto-journals/plos/partials/before-bib.tex","_extensions/quarto-journals/plos/partials/biblio.tex"],"natbiboptions":"numbers,square,comma","code-block-border-left":false,"revealjs-plugins":[],"manuscript":{"article":"index.qmd","notebooks":[{"notebook":"index.qmd","title":"Article Notebook"}],"mecaFile":"index-meca.zip"},"quarto-internal":{"subarticles":[{"input":"/home/adit/R.project/lapsus_sle_graves/index.qmd","token":"nb-article","render":true}]},"notebook-preview-options":{"back":true},"theme":"cosmo","title-block-style":"manuscript","lightbox":"auto","title":"Penyakit Graves pada seorang perempuan dengan Sistemik Lupus Eritematosus","authors":[{"name":"dr. Kadek Adit Wiryadana","affiliation":"Universitas Udayana","roles":"writing","corresponding":true},{"name":"dr. I Made Siswadi Semadi, M.Biomed, SpPD, K-EMD","affiliation":"Universitas Udayana","roles":"writing","corresponding":false},{"name":"dr. Pande Ketut Kurniari, SpPD, K-R","affiliation":"Universitas Udayana","roles":"writing","corresponding":false}],"bibliography":["references.bib"],"google-scholar":true,"clear-hidden-classes":"none","remove-hidden":"all","unroll-markdown-cells":true},"extensions":{"book":{"selfContainedOutput":true}}}},"projectFormats":["html","docx","jats","plos-pdf"]}